Story perspectives

Breakthrough Studies Explore Psychedelics for Anxiety Relief

10/10/2025

37 7

Summary

Story summary

Dr. Maurizio Fava's phase 2 trial found that a single high dose of LSD significantly reduced anxiety symptoms in patients with Generalized Anxiety Disorder (GAD) for up to 12 weeks.
Researchers at Kingston Health Sciences Centre are conducting Canada's first Health Canada-approved trial on micro-doses of psilocybin taken at home to alleviate anxiety without psychedelic effects.
These studies address the urgent need for effective GAD treatments, which currently affect over 1.6 million Canadians.

1 of 1

Story summary

Dr. Maurizio Fava's phase 2 trial found that a single high dose of LSD significantly reduced anxiety symptoms in patients with Generalized Anxiety Disorder (GAD) for up to 12 weeks.
Researchers at Kingston Health Sciences Centre are conducting Canada's first Health Canada-approved trial on micro-doses of psilocybin taken at home to alleviate anxiety without psychedelic effects.
These studies address the urgent need for effective GAD treatments, which currently affect over 1.6 million Canadians.